Basilea Pharmaceutica AG Share Price Xetra
Stocks
PK5
CH0011432447
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.65 EUR | 0.00% |
|
0.00% | - |
| Market Cap | 648M 793M 698M 596M 1.12B 76.84B 1.14B 7.75B 3.02B 37.48B 2.98B 2.91B 130B | P/E 2026 * |
13.9x | P/E 2027 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 496M 607M 534M 456M 856M 58.79B 871M 5.93B 2.31B 28.68B 2.28B 2.23B 99.49B | EV / Sales 2026 * |
1.89x | EV / Sales 2027 * | 1.63x |
| Free-Float |
91.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Basilea Pharmaceutica AG
| Manager | Title | Age | Since |
|---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 61 | 18/04/2018 |
Adesh Kaul
DFI | Director of Finance/CFO | 52 | 09/04/2019 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 62 | 30/04/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Werner
BRD | Director/Board Member | 70 | 28/11/2011 |
| Chairman | 71 | 08/04/2013 | |
Nicole Onetto
BRD | Director/Board Member | 73 | 26/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 793M | |
| +1.00% | -3.73% | -3.50% | +12.58% | 46.35B | |
| +3.13% | +5.34% | +402.93% | +605.08% | 40.13B | |
| +2.14% | +2.95% | +10.83% | +65.45% | 36.33B | |
| +4.43% | -1.51% | +6.73% | -9.17% | 34.6B | |
| +1.23% | -2.05% | +0.56% | +30.76% | 26.77B | |
| +0.29% | -2.75% | - | - | 16.66B | |
| +14.71% | +12.62% | +38.50% | +146.99% | 16.91B | |
| -0.91% | -6.77% | -0.58% | +7.06% | 13.05B | |
| +1.82% | +0.19% | +1.45% | -30.74% | 13.05B | |
| Average | +2.64% | +0.47% | +57.12% | +103.50% | 27.09B | |
| Weighted average by Cap. | +2.62% | +0.23% | +76.20% | +131.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 263M 322M 283M 242M 453M 31.16B 462M 3.14B 1.23B 15.2B 1.21B 1.18B 52.73B | 267M 327M 288M 246M 461M 31.7B 470M 3.2B 1.25B 15.46B 1.23B 1.2B 53.65B |
| Net income | 51.57M 63.12M 55.51M 47.43M 88.94M 6.11B 90.54M 617M 241M 2.98B 237M 232M 10.34B | 39.24M 48.03M 42.24M 36.09M 67.68M 4.65B 68.89M 469M 183M 2.27B 180M 176M 7.87B |
| Net Debt | -152M -186M -164M -140M -263M -18.05B -267M -1.82B -710M -8.8B -700M -684M -30.54B | -213M -260M -229M -196M -367M -25.2B -373M -2.54B -992M -12.29B -977M -956M -42.64B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- BSLN Stock
- PK5 Stock
Select your edition
All financial news and data tailored to specific country editions
